Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Zealand Pharma will use Generate:Biomedicines' generative AI platform to develop protein treatments for obesity and metabolic diseases under a deal worth up to $1.2 billion.
Waterdrop's 2025 ESG report says its KEYI.AI underwriting system reduced processing time for complex health insurance cases by 80% and achieved 99.8% accuracy.
Sunbound acquired Richter Healthcare Consultants and closed a $24 million Series A round led by TTV Capital. The deal adds revenue cycle, accounting and consulting services for senior care operators to Sunbound's software platform.
SciBase secured its first medical policy from a private US insurer covering the use of Nevisense to assess certain suspicious skin lesions.
TumorSight Risk analyzes breast MRI, pathology and clinical data to estimate recurrence risk at five and ten years for certain patients with early stage breast cancer.
HIMSS27 will take place April 5 to 8, 2027, in Chicago, with more than 600 education sessions and over 900 exhibitors.
wisepatientAI now lets patients ask questions about their medical history and receive answers based on records collected from multiple providers.
GenoMorph identified about 2,300 regulatory DNA candidates associated with bird beak size and shape, providing targets for testing in the dodo restoration program.
Likang Life Sciences will present its AI based neoantigen discovery platform at the Abu Dhabi Future Health Summit 2026, held October 20 to 22.
INmune Bio and Quantum Computing Inc. will use quantum optimization, AI and data analytics to identify potential disease indications and biomarkers for the investigational treatment XPro.
WeInfuse and Clarion have partnered to connect AI agents with infusion and pharmacy data. The agents handle routine patient calls using current order, authorization and appointment information.
Brainomix and the Pulmonary Fibrosis Foundation will study how patients and caregivers understand quantitative CT results from the e-Lung imaging tool.
Illumina launched a unified software environment that combines genomic analysis applications, AI models and curated biological data.
PhaseV says its causal model predicted weight changes, adverse events and treatment dropout among patients taking GLP-1 and related incretin medications.
OPRA 26.2 adds an AI agent that analyzes clinical trial protocols and drafts risk assessments for human review.
OpenEvidence and Johns Hopkins Medicine will develop an AI focused medical education model and clinical tools that combine research evidence with patient histories.
Stryker plans to invest about $400 million in CMR Surgical and become the exclusive U.S. sales agent for its Versius surgical robot portfolio.
Suvoda is making its Sofia AI assistant, which can take authorized system actions with an audit trail, available for all new trials using its RTSM/IRT or eCOA products.
HealthpointCapital has made a significant investment in Ospitek, which provides AI software for surgical operations and patient flow. Financial terms were not disclosed.
Stephen Harrison will direct Prologue Medicines' scientific strategy and the development of its DELVE machine learning platform and drug pipeline.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
